Infectious Disease


no image

What Can Donors Learn from HIV in Responding to Ebola?

This is a joint post with Alan Whiteside, CIGI Chair in Global Health Policy, BSIA and Professor Emeritus, University of KwaZulu-Natal. Since the first case of Ebola appeared last year, the virus has infected nearly 10,000 people.  The epidemic is concentrated in Liberia, Sierra Leone, and Guinea — post-conflict countries with incredibly weak health systems. It stands to have severe health, social, and economic consequences and is arguably the most pressing challenge to global health security the world has faced in decades

Screen Shot 2014-10-23 at 10.37.15 AM

New Ebola Timeline

This interactive timeline chronicles key events, publications and research since the discovery of Ebola in 1976 through the present 2014 West Africa outbreak. We have Read More


Six Reasons an Ebola Travel Ban Makes Us No Safer — and No Sense

Momentum seems to be building on Capitol Hill for some kind of West African travel ban as an anti-Ebola measure. It sounds like a simple solution. But here’s why a travel ban is pointless—or could even make us less safe.   Zero direct flights. There are no direct flights between the US and the three affected countries.


News Outlets Report On Issues Surrounding Ebola Vaccine Development

News outlets report on various issues surrounding the development and testing of Ebola vaccines. Financial Times: Industry response to Ebola quickens (Ward, 10/23). Forbes: Head of GSK Ebola Vaccine Research: “Can We Even Consider Doing A Trial?” (Munro, 10/23). New York Times: Ebola Vaccine, Ready for Test, Sat on the Shelf (Grady, 10/23). New York…More

Ebola Efforts In West Africa Must Increase To Bring Outbreak Under Control, Study Says

News outlets report on a study published in The Lancet Infectious Diseases that says the world’s response to the West African Ebola outbreak must be bolstered to prevent tens of thousands of deaths. The Guardian: Response to Ebola epidemic in West Africa too slow, say scientists “The international response to the Ebola epidemic in West…More

Evaluation of a Community-Based Trapping Program to Collect Simulium ochraceum sensu lato for…

by Mario A. Rodríguez-Pérez, Monsuru A. Adeleke, Isabel C

Current Treatment for Venom-Induced Consumption Coagulopathy Resulting from Snakebite

by Kalana Maduwage, Geoffrey K. Isbister Venomous snakebite is considered the single most important cause of human injury from venomous animals worldwide.

P. vivax Malaria and Dengue Fever Co-infection: A Cross-Sectional Study in the Brazilian Amazon

by Belisa M. L.

A One Health Framework for the Evaluation of Rabies Control Programmes: A Case Study from…

by Barbara Häsler, Elly Hiby, Will Gilbert, Nalinika Obeyesekere, Houda Bennani, Jonathan Rushton Background One Health addresses complex challenges to promote the health of all species and the environment by integrating relevant sciences at systems level. Its application to zoonotic diseases is recommended, but few coherent frameworks exist that combine approaches from multiple disciplines. Rabies requires an interdisciplinary approach for effective and efficient management

Chemotherapeutic Potential of 17-AAG against Cutaneous Leishmaniasis Caused by Leishmania…

by Diego M. Santos, Antonio L. O

Caseating Granulomas in Cutaneous Leishmaniasis

by Jessica Aoun, Robert Habib, Khalil Charaffeddine, Suad Taraif, Asif Loya, Ibrahim Khalifeh Background Caseating granulomas are often associated with a mycobacterial infection (TB) and are thought to be exceedingly rare in cutaneous leishmaniasis (CL). However, no large series has accurately documented the incidence of caseating granulomas in CL. Methods A multiregional cohort consisting of 317 patients with CL [Syria (157), Pakistan (66), Lebanon (47), Saudi Arabia (43), Ethiopia (2) and Iran (2)] was reviewed

Hidden Population Structure and Cross-species Transmission of Whipworms (Trichuris sp.) in…

by Ria R. Ghai, Noah D. Simons, Colin A.

IgG1 as a Potential Biomarker of Post-chemotherapeutic Relapse in Visceral Leishmaniasis, and…

by Tapan Bhattacharyya, Armon Ayandeh, Andrew K. Falconar, Shyam Sundar, Sayda El-Safi, Marissa A. Gripenberg, Duncan E

First WHO Meeting of Stakeholders on Elimination of Gambiense Human African Trypanosomiasis

by Peter Holmes

Identification and Characterization of Hundreds of Potent and Selective Inhibitors of…

by Rosario Diaz, Sandra A. Luengo-Arratta, João D. Seixas, Emanuele Amata, William Devine, Carlos Cordon-Obras, Domingo I.

Multiplexed Digital mRNA Profiling of the Inflammatory Response in the West Nile Swiss Webster…

by José Peña, Jessica A. Plante, Alda Celena Carillo, Kimberly K. Roberts, Jennifer K

Marketing approval for UMT from the Nigeria NAFDAC

Fyodor Biotechnologies Inc. has sponsored a study to evaluate the clinical performance of the one-step Fyodor Urine Malaria Test (UMT), to determine its accuracy (sensitivity and specificity) for the diagnosis of Plasmodium falciparum malaria in febrile patients. A total of 1500 properly consented children and adults presenting with fever (axillary temperature ?37.5°C) or history of fever in the last 48 hours (Group 1), 250 apparently “healthy” individuals (Control, Group 2), and 50 patients with Schistosoma hematobium and Rheumatoid arthritis (Group 3), were recruited. Matched urine and fingerprick (capillary) blood samples were collected and tested using the UMT and, Binax NOW® malaria rapid diagnostic test (blood test) and thick smear microscopy, respectively.

Older Posts »